|
About Us
History
ProSci Incorporated is a privately-held biotech firm located in San Diego, California. A leader in its field, ProSci focuses its
energies in Antibody Research Products, Custom Antibody / Immunochemistry Services and Research Programs. By combining its specializations
in each of these disciplines, ProSci is able to provide its customers with practical experience, innovative products, competitive pricing,
high-quality research tools, and customized services.
Research Antibodies
ProSci Incorporated specializes in the production of affinity-purified peptide-specific polyclonal antibodies to novel antigens in fields
such as Apoptosis, HIV/Chemokine Receptors, Signal Transduction, Neurobiology and Immunology. To date, ProSci has released more than 140
antibodies in these fields, with 70 more currently in development. The majority of these antibodies are directed towards apoptotic regions,
where ProSci has targeted more than 80 proteins of interest. All Polyclonal Research Antibodies offered by ProSci are affinity-purified,
which allows for the isolation of antibodies specific to the epitope of interest. As a result, ProSci's antibodies have the same specificity
as monoclonal antibodies at a price well below competitors' polyclonal antibodies. In addition, ProSci offers a complete assortment of cell
lysates, tissue lysates and peptides to complement the use of these antibodies.
Custom Antibody Services
In line with its research product offerings, ProSci offers custom polyclonal and monoclonal antibody production services using its own
animal facilities in San Diego, California. To enhance the value and accuracy of these custom produced antibodies, ProSci provides a
complete spectrum of immunochemistry services. These include antigen design assistance, antibody characterization, peptide synthesis,
protein conjugation, IgG and affinity purification, ELISA, Western Blot Mass Spectrometry, and Immunohistochemistry. To learn more about
these services, please visit our FAQ page.
Research Programs
In conjunction with its strengths in the antibody and reagent market, ProSci Incorporated actively conducts research in a variety of
fields. Most notably, ProSci is testing a novel tumor marker for diagnostic and therapeutics applications. In addition, ProSci is
performing research in fields such as AIDS vaccine development, stem cells, proteomics and bioterrorism. This capacity to innovate
again becomes a service for the customer, as it allows ProSci to offer contract research alliances with outside institutions. In
such situations, ProSci provides large-scale customized immunochemistry services tailored to the needs of the institution, thereby
permitting the reduction of research costs, the outsourcing of immunochemistry services and the incorporation of high-grade antibody
products into research projects.
Why our prices are low
Having been in the industry for so many years, ProSci owns all of its facilities, and therefore benefits from low overhead and fixed
costs. In addition, because these facilities produce such a large number of antibodies per year, ProSci enjoys significant
economies-of-scale, thereby reducing per-animal costs. Above all, these prices do not translate into lower-grade products as
experience has enabled ProSci to continually improve the quality of its antibodies.
How we can enhance your research programs
In the end, the use of these services allows the researcher to reduce research expenses, outsource specialized immunochemistry
services and incorporate quality products into the research process. Moreover, our own experience in using these products and
services for research purposes enables us to provide the customer with detailed and relevant advice concerning the use of
antibody and immunochemistry technologies. To this end, we invite you to explore our custom antibody and immunochemistry service
offerings.
|
|